Vaccination Clinical Trial
— Info-VacOfficial title:
Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization
The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio. In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended. The vaccination coverage for patients over 16 years of age is insufficient in France.
Status | Recruiting |
Enrollment | 2125 |
Est. completion date | September 1, 2022 |
Est. primary completion date | June 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 25 Years to 25 Years |
Eligibility | Inclusion Criteria: - aged 25 years old in 2020 - without delivery of DTPolio vaccine in 2019 or 2020 Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
France | Université de Reims Champagne-Ardenne | Reims |
Lead Sponsor | Collaborator |
---|---|
Université de Reims Champagne-Ardenne |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | DTPolio vaccine delivery | DTPolio vaccine delivery by pharmacies within 12 months of sending information about booster vaccination against DTPolio at 25 years | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
Recruiting |
NCT05996549 -
Cost-effectiveness of the Influenza Vaccination
|
Phase 4 | |
Completed |
NCT04323137 -
Encouraging Flu Vaccination Among High-Risk Patients Identified by ML
|
N/A | |
Completed |
NCT01224301 -
School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities
|
N/A | |
Completed |
NCT00169858 -
Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections
|
Phase 4 | |
Completed |
NCT05509283 -
Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications
|
N/A | |
Completed |
NCT02907580 -
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
|
N/A | |
Recruiting |
NCT06160999 -
Improving Uptake of Pediatric Vaccines Through Religious Conferences and Vaccines-in-a-van in Aceh, Indonesia
|
N/A | |
Recruiting |
NCT03875703 -
Post-Vaccination Biological Collection
|
||
Completed |
NCT03287830 -
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
|
N/A | |
Completed |
NCT02907645 -
Influenza Vaccine Randomized Educational Trial: Adult
|
N/A | |
Completed |
NCT03220555 -
Efficacy of the Buzzy® Device on the Prevention of Health Care Induced Pediatric Pain in a Vaccination Center
|
N/A | |
Withdrawn |
NCT05023512 -
Understanding Public Attitudes Towards the COVID-19 Vaccination
|
N/A | |
Recruiting |
NCT02937428 -
To Look or Not to Look at the Needle During Vaccination
|
Phase 3 | |
Completed |
NCT00813319 -
Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
|
Phase 3 | |
Completed |
NCT03104790 -
Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls
|
Phase 4 | |
Completed |
NCT04780867 -
Psychological and Lifestyle Factors on Health Outcomes
|
N/A | |
Completed |
NCT03239795 -
Promoting Influenza Vaccination In General Practice Waiting Rooms
|
N/A |